Truist upgraded Krispy Kreme (DNUT) to Buy from Hold with a price target of $15, up from $13, after spending time with management. The analyst came away from the meetings with the belief the Krispy Kreme story is either unknown or misunderstood by most investors. Investors are undervaluing the potential of the company’s recently announced partnership with McDonald’s (MCD), the analyst tells investors in a research note. The firm says the partnership will accelerate the revenue growth of Krispy Kreme’s legacy business in the next few quarters, well before the McDonald’s rollout is complete. It also believes the weight loss drug overhang is fully reflected in Krispy Kreme’s current valuation.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DNUT: